| scholarly article | Q13442814 |
| P50 | author | Jean M Whichard | Q92518995 |
| P2093 | author name string | Kevin Joyce | |
| Jason P Folster | |||
| Maria Sjölund-Karlsson | |||
| Felicita Medalla | |||
| Gary Pecic | |||
| Regan Rickert | |||
| P2860 | cites work | FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States | Q34314737 |
| The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
| Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China | Q35102456 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli | Q35879095 | ||
| Mechanisms of resistance to quinolones | Q36155441 | ||
| Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States | Q37121208 | ||
| Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada | Q37568365 | ||
| Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs | Q42355473 | ||
| Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China | Q43642058 | ||
| Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital | Q45070846 | ||
| Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark | Q46577820 | ||
| Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong | Q46610576 | ||
| Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr | Q46736529 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica | Q50079326 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| quinolones | Q426549 | ||
| Salmonella enterica | Q2264864 | ||
| P304 | page(s) | 2142-2144 | |
| P577 | publication date | 2009-02-17 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States | |
| P478 | volume | 53 |
| Q60303182 | Antimicrobial resistance, plasmid, virulence, multilocus sequence typing and pulsed-field gel electrophoresis profiles of Salmonella enterica serovar Typhimurium clinical and environmental isolates from India |
| Q36042373 | Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study |
| Q36173968 | Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica |
| Q28084595 | Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections |
| Q36173899 | Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected]. |
| Q37643475 | Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin |
| Q64137776 | Identification and Characterization of Salmonella enterica Serotype Newport Isolates with Decreased Susceptibility to Ciprofloxacin in the United States |
| Q38023251 | In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards |
| Q38632309 | National Antimicrobial Resistance Monitoring System: Two Decades of Advancing Public Health Through Integrated Surveillance of Antimicrobial Resistance |
| Q35804933 | Plasmid-mediated Quinolone Resistance among Non-TyphiSalmonella entericaIsolates, USA |
| Q34888920 | Plasmid-mediated quinolone resistance |
| Q56561842 | Plasmid-mediated quinolone resistance in human non-typhoidal Salmonella infections: An emerging public health problem in the United States |
| Q24645356 | Plasmid-mediated quinolone resistance: a multifaceted threat |
| Q46855239 | Prevalence, characterization and antibiotic resistance of Salmonella isolates in large corvid species of europe and north America between 2010 and 2013. |
| Q35128681 | Serotypes, seasonal trends, and antibiotic resistance of non-typhoidal Salmonella from human patients in Guangdong Province, China, 2009-2012. |
Search more.